Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
In silico toxicity evaluation using Derek® Nexus for quicker and cost-effective screening for skin sensitization phototoxicity, hepatotoxicity, and in vitro hERG channel inhibition
Presenting the data for purification of Retro virus using ion exchange chromatography where the condition for purification was optimized.
Our approach to informed decision-making during early discovery stage to create novel, best-in-class drugs.
Case studies on how Syngene handled unique problems in Stability Testing arising from packaging material.
Syngene’s ‘first-time-right’ Technology Transfer approach to achieve timely clinical and commercial milestones.
How to manage the risk of drug-drug interactions in drug development and during poly therapy especially with elderly patients.
Demonstrating the therapeutic edge of targeting CEACAM7 in pancreatic cancer using an integrative approach between biology and bioinformatics.